A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF OP-1250 MONOTHERAPY VS STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2- ADVANCED OR METASTATIC BREAST CANCER FOLLOWING ENDOCRINE AND CDK 4/6 INHIBITOR THERAPY (OPERA-01)

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Cherry Creek Medical Center
CTRC Inpatient
Highlands Ranch Hospital
Lone Tree Medical Center
University of Colorado Hospital

Principal Investigator
Photograph of Virginia Borges

Virginia Borges

Study ID

Protocol Number: 23-2036

More information available at ClinicalTrials.gov: NCT06016738

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers